524711 — Vista Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹677.68m
- IN₹756.38m
- IN₹102.88m
- 24
- 15
- 52
- 16
Annual cashflow statement for Vista Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39.4 | -36.6 | -25.6 | -58.8 | -51.8 |
| Depreciation | |||||
| Non-Cash Items | 5.61 | 15.2 | 8.33 | 12.1 | 12.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 28.3 | -53.4 | 1.19 | 23.4 | -16.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8.03 | -67.5 | -9.93 | -17.1 | -49.1 |
| Capital Expenditures | -17.3 | -2.99 | -0.143 | -12.7 | -7.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -17.3 | -2.99 | -0.143 | -12.7 | -7.9 |
| Financing Cash Flow Items | -15.4 | -15.5 | 2.65 | -15.6 | -12.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.8 | 69.6 | 9.39 | 31.1 | 55.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.42 | -0.852 | -0.68 | 1.32 | -1.09 |